{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T01:45:11Z","timestamp":1794361511010,"version":"4.9.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T00:00:00Z","timestamp":1721001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T00:00:00Z","timestamp":1721001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005111","name":"Rigshospitalet","doi-asserted-by":"publisher","award":["E-23565-02"],"award-info":[{"award-number":["E-23565-02"]}],"id":[{"id":"10.13039\/501100005111","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005111","name":"Rigshospitalet","doi-asserted-by":"publisher","award":["E-23565-03"],"award-info":[{"award-number":["E-23565-03"]}],"id":[{"id":"10.13039\/501100005111","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001734","name":"Copenhagen University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001734","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Insertion of an external ventricular drain (EVD) is a first-line treatment of acute hydrocephalus caused by aneurysmal subarachnoid haemorrhage (aSAH). Once the patient is clinically stable, the EVD is either removed or replaced by a permanent internal shunt. The optimal strategy for cessation of the EVD is unknown. Prompt closure carries a risk of acute hydrocephalus or redundant shunt implantations, whereas gradual weaning may increase the risk of EVD-related infections.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      DRAIN (\n                      <jats:italic>Danish RAndomised Trial of External Ventricular Drainage Cessation IN Aneurysmal Subarachnoid Haemorrhage<\/jats:italic>\n                      ) is an international multicentre randomised clinical trial comparing prompt closure versus gradual weaning of the EVD after aSAH. The primary outcome is a composite of VP-shunt implantation, all-cause mortality, or EVD-related infection. Secondary outcomes are serious adverse events excluding mortality and health-related quality of life (EQ-5D-5L). Exploratory outcomes are modified Rankin Scale, Fatigue Severity Scale, Glasgow Outcome Scale Extended, and length of stay in the neurointensive care unit and hospital. Outcome assessment will be performed 6\u00a0months after ictus. Based on the sample size calculation (event proportion 80% in the gradual weaning group, relative risk reduction 20%, alpha 5%, power 80%), 122 participants are required in each intervention group. Outcome assessment for the primary outcome, statistical analyses, and conclusion drawing will be blinded. Two independent statistical analyses and reports will be tracked using a version control system, and both will be published. Based on the final statistical report, the blinded steering group will formulate two abstracts.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We present a pre-defined statistical analysis plan for the randomised DRAIN trial, which limits bias, p-hacking, and data-driven interpretations. This statistical analysis plan is accompanied by tables with simulated data, which increases transparency and reproducibility.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>ClinicalTrials.gov identifier: NCT03948256. Registered on May 13, 2019.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-024-08305-4","type":"journal-article","created":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T09:02:01Z","timestamp":1721034121000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prompt closure versus gradual weaning of external ventricular drain for hydrocephalus following aneurysmal subarachnoid haemorrhage: a statistical analysis plan for the DRAIN randomised clinical trial"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6968-1938","authenticated-orcid":false,"given":"Tenna","family":"Capion","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Lilja-Cyron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Juhler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"M\u00f8ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika","family":"Sorteberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e5l Andr\u00e9","family":"R\u00f8nning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frantz Rom","family":"Poulsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joakim","family":"Wismann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders Emil","family":"Schack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celina","family":"Ravlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f8rgen","family":"Isaksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Lindschou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Gluud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiit","family":"Mathiesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus Harboe","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,15]]},"reference":[{"key":"8305_CR1","doi-asserted-by":"publisher","unstructured":"Pavesi G, Nasi D, Moriconi E, Stanzani R, Puzzolante A, Lucchesi L, et al. Management and safety of intraoperative ventriculostomy during early surgery for ruptured intracranial aneurysms. Acta Neurochir (Wien) [Internet]. Springer Vienna; 2022;164:2909\u201316. Available from: \nhttps:\/\/doi.org\/10.1007\/s00701-022-05346-z.","DOI":"10.1007\/s00701-022-05346-z"},{"key":"8305_CR2","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/brain\/124.2.249","volume":"124","author":"J van Gijn","year":"2001","unstructured":"van Gijn J, Rinkel GJ. Subarachnoid haemorrhage: diagnosis, causes and management. Brain. 2001;124:249\u201378.","journal-title":"Brain"},{"key":"8305_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fneur.2013.00179","volume":"4","author":"TM Ellmore","year":"2013","unstructured":"Ellmore TM, Rohlffs F, Khursheed F. fMRI of working memory impairment after recovery from subarachnoid hemorrhage. Front Neurol. 2013;4:1\u201313.","journal-title":"Front Neurol."},{"key":"8305_CR4","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.wneu.2017.06.119","volume":"106","author":"Z Xie","year":"2017","unstructured":"Xie Z, Hu X, Zan X, Lin S, Li H, You C. Predictors of shunt-dependent hydrocephalus after aneurysmal subarachnoid hemorrhage? A systematic review and meta-analysis. World Neurosurg. 2017;106:844-860.e6.","journal-title":"World Neurosurg"},{"key":"8305_CR5","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3171\/jns.2004.100.2.0225","volume":"100","author":"JD Klopfenstein","year":"2004","unstructured":"Klopfenstein JD, Kim LJ, Feiz-Erfan I, Hott JS, Goslar P, Zabramski JM, et al. Comparison of rapid and gradual weaning from external ventricular drainage in patients with aneurysmal subarachnoid hemorrhage: a prospective randomized trial. J Neurosurg. 2004;100:225\u20139.","journal-title":"J Neurosurg"},{"key":"8305_CR6","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/s12028-016-0352-9","volume":"26","author":"DY Chung","year":"2017","unstructured":"Chung DY, Leslie-Mazwi TM, Patel AB, Rordorf GA. Management of external ventricular drains after subarachnoid hemorrhage: a multi-institutional survey. Neurocrit Care. 2017;26:356\u201361.","journal-title":"Neurocrit Care."},{"key":"8305_CR7","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s00701-016-3039-2","volume":"159","author":"J Wid\u00e9n","year":"2017","unstructured":"Wid\u00e9n J, Eriksson BM, Ronne-Engstr\u00f6m E, Enblad P, Westman G. Ventriculostomy-related infections in subarachnoid hemorrhage patients\u2014a retrospective study of incidence, etiology, and antimicrobial therapy. Acta Neurochir (Wien). 2017;159:317\u201323. https:\/\/doi.org\/10.1007\/s00701-016-3039-2.","journal-title":"Acta Neurochir (Wien)"},{"key":"8305_CR8","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1161\/STR.0b013e3182587839","volume":"43","author":"ES Connolly","year":"2012","unstructured":"Connolly ES, Rabinstein AA, Carhuapoma JR, Derdeyn CP, Dion J, Higashida RT, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the american heart association\/american stroke association. Stroke. 2012;43:1711\u201337.","journal-title":"Stroke."},{"key":"8305_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/aas.14263","volume":"67","author":"T Capion","year":"2023","unstructured":"Capion T, Lilja-cyron A, Olsen MH, Juhler M, M\u00f8ller K, Sorteberg A, et al. Prompt closure versus gradual weaning of external ventricular drainage for hydrocephalus following aneurysmal subarachnoid haemorrhage: protocol for the DRAIN randomised clinical trial. Acta Anaesthesiol Scand. 2023;67:1\u20137.","journal-title":"Acta Anaesthesiol Scand."},{"key":"8305_CR10","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1001\/jama.2017.18556","volume":"318","author":"C Gamble","year":"2017","unstructured":"Gamble C, Krishan A, Stocken D, Lewis S, Juszczak E, Dor\u00e9 C, et al. Guidelines for the content of statistical analysis plans in clinical trials. JAMA - J Am Med Assoc. 2017;318:2337\u201343.","journal-title":"JAMA - J Am Med Assoc"},{"key":"8305_CR11","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","volume":"20","author":"M Herdman","year":"2011","unstructured":"Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20:1727\u201336.","journal-title":"Qual Life Res"},{"key":"8305_CR12","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1001\/archneur.1989.00520460115022","volume":"46","author":"LB Krupp","year":"1989","unstructured":"Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46:1121\u20133.","journal-title":"Arch Neurol."},{"key":"8305_CR13","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1161\/01.STR.0000258355.23810.c6","volume":"38","author":"JL Banks","year":"2007","unstructured":"Banks JL, Marotta CA. Outcomes validity and reliability of the modified rankin scale: Implications for stroke clinical trials - a literature review and synthesis. Stroke. 2007;38:1091\u20136.","journal-title":"Stroke"},{"key":"8305_CR14","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s00415-008-0796-8","volume":"255","author":"N Weisscher","year":"2008","unstructured":"Weisscher N, Vermeulen M, Roos YB, De Haan RJ. What should be defined as good outcome in stroke trials; a modified Rankin score of 0\u20131 or 0\u20132? J Neurol. 2008;255:867\u201374.","journal-title":"J Neurol"},{"key":"8305_CR15","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1089\/neu.1998.15.573","volume":"15","author":"JTL Wilson","year":"1998","unstructured":"Wilson JTL, Pettigrew LEL, Teasdale GM. Structured interviews for the glasgow outcome scale and the extended glasgow outcome scale: guidelines for their use. J Neurotrauma. 1998;15:573\u201380.","journal-title":"J Neurotrauma"},{"key":"8305_CR16","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/S0140-6736(20)32518-6","volume":"397","author":"R Post","year":"2021","unstructured":"Post R, Germans MR, Tjerkstra MA, Vergouwen MDI, Jellema K, Koot RW, et al. Ultra-early tranexamic acid after subarachnoid haemorrhage (ULTRA): a randomised controlled trial. Lancet. 2021;397:112\u20138.","journal-title":"Lancet"},{"key":"8305_CR17","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1161\/STROKEAHA.117.017956","volume":"49","author":"CS Gathier","year":"2018","unstructured":"Gathier CS, Van Den Bergh WM, Van Der Jagt M, Verweij BH, Dankbaar JW, M\u00fcller MC, et al. Induced hypertension for delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage a randomized clinical trial. Stroke. 2018;49:76\u201383.","journal-title":"Stroke"},{"key":"8305_CR18","doi-asserted-by":"publisher","unstructured":"Riberholt CG, Gluud C, Jakobsen JC, Ovesen C, Mehlsen J, M\u00f8ller K. Statistical analysis plan: Early mobilization by head-up tilt with stepping versus standard care after severe traumatic brain injury. Contemp Clin Trials Commun. 2021;24:100856. https:\/\/doi.org\/10.1016\/j.conctc.2021.100856.","DOI":"10.1016\/j.conctc.2021.100856"},{"key":"8305_CR19","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s11136-014-0834-1","volume":"24","author":"D Golicki","year":"2015","unstructured":"Golicki D, Niewada M, Buczek J, Karli\u0144ska A, Kobayashi A, Janssen MF, et al. Validity of EQ-5D-5L in stroke. Qual Life Res. 2015;24:845\u201350.","journal-title":"Qual Life Res"},{"key":"8305_CR20","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1007\/s11136-015-1196-z","volume":"25","author":"P Chen","year":"2016","unstructured":"Chen P, Lin KC, Liing RJ, Wu CY, Chen CL, Chang KC. Validity, responsiveness, and minimal clinically important difference of EQ-5D-5L in stroke patients undergoing rehabilitation. Qual Life Res Springer International Publishing. 2016;25:1585\u201396.","journal-title":"Qual Life Res Springer International Publishing"},{"key":"8305_CR21","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1136\/bmjopen-2018-027092","volume":"9","author":"JC Jakobsen","year":"2019","unstructured":"Jakobsen JC, Ovesen C, Winkel P, Hilden J, Gluud C, Wetterslev J. Power estimations for non-primary outcomes in randomised clinical trials. BMJ Open. 2019;9:2018\u201320.","journal-title":"BMJ Open"},{"key":"8305_CR22","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/S0197-2456(96)00129-8","volume":"18","author":"J Zhang","year":"1997","unstructured":"Zhang J, Quan H, Ng J, Stepanavage ME. Some statistical methods for multiple endpoints in clinical trials. Control Clin Trials. 1997;18:204\u201321.","journal-title":"Control Clin Trials"},{"key":"8305_CR23","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1136\/bmjebm-2019-111268","volume":"26","author":"AK N\u00f8rskov","year":"2021","unstructured":"N\u00f8rskov AK, Lange T, Nielsen EE, Gluud C, Winkel P, Beyersmann J, et al. Assessment of assumptions of statistical analysis methods in randomised clinical trials: the what and how. BMJ evidence-based Med. 2021;26:121\u20136.","journal-title":"BMJ evidence-based Med"},{"key":"8305_CR24","doi-asserted-by":"crossref","unstructured":"Kawaguchi A, Koch GG. Sanon: an R package for stratified analysis with nonparametric covariable adjustment. J Stat Softw. 2015;67.","DOI":"10.18637\/jss.v067.i09"},{"key":"8305_CR25","doi-asserted-by":"crossref","unstructured":"Jakobsen JC, Tamborrino M, Winkel P, Haase N, Perner A, Wetterslev J, et al. Count Data Analysis in Randomised Clinical Trials. J Biom Biostat. 2015.","DOI":"10.4172\/2155-6180.1000227"},{"key":"8305_CR26","doi-asserted-by":"publisher","unstructured":"Ehsanes Saleh AKM. Hodges-lehmann estimate of the location parameter in censored samples. Ann Inst Stat Math. 1976;28:235\u201347. Available from: https:\/\/doi.org\/10.1007\/BF02504742.","DOI":"10.1007\/BF02504742"},{"key":"8305_CR27","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1161\/STROKEAHA.106.474080","volume":"38","author":"PMW Bath","year":"2007","unstructured":"Bath PMW, Gray LJ, Collier T, Pocock S, Carpenter J. Can we improve the statistical analysis of stroke trials? Statistical reanalysis of functional outcomes in stroke trials. Stroke. 2007;38:1911\u20135.","journal-title":"Stroke"},{"key":"8305_CR28","doi-asserted-by":"crossref","unstructured":"Roozenbeek B, Lingsma HF, Perel P, Edwards P, Roberts I, Murray GD, et al. The added value of ordinal analysis in clinical trials: an example in traumatic brain injury. Crit Care. BioMed Central Ltd; 2011;15:R127. Available from: \nhttp:\/\/ccforum.com\/content\/15\/3\/R127.","DOI":"10.1186\/cc10240"},{"key":"8305_CR29","doi-asserted-by":"publisher","first-page":"982","DOI":"10.21037\/atm-2020-57","volume":"8","author":"J Liang","year":"2020","unstructured":"Liang J, Bi G, Zhan C. Multinomial and ordinal logistic regression analyses with multi-categorical variables using R. Ann Transl Med. 2020;8:982\u2013982.","journal-title":"Ann Transl Med"},{"key":"8305_CR30","doi-asserted-by":"publisher","first-page":"E1951","DOI":"10.1212\/WNL.0000000000006554","volume":"91","author":"A Ganesh","year":"2018","unstructured":"Ganesh A, Luengo-Fernandez R, Wharton RM, Rothwell PM. Ordinal vs dichotomous analyses of modified rankin scale, 5-year outcome, and cost of stroke. Neurology. 2018;91:E1951\u201360.","journal-title":"Neurology"},{"key":"8305_CR31","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1161\/STROKEAHA.123.044790","volume":"55","author":"AM Mistry","year":"2024","unstructured":"Mistry AM, Saver J, Mack W, Kamel H, Elm J, Beall J. Subarachnoid hemorrhage trials: cutting, sliding, or keeping mRS scores and WFNS grades. Stroke. 2024;55:779\u201384.","journal-title":"Stroke."},{"key":"8305_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12874-017-0442-1","volume":"17","author":"JC Jakobsen","year":"2017","unstructured":"Jakobsen JC, Gluud C, Wetterslev J, Winkel P. When and how should multiple imputation be used for handling missing data in randomised clinical trials - a practical guide with flowcharts. BMC Med Res Methodol. 2017;17:1\u201310.","journal-title":"BMC Med Res Methodol."},{"key":"8305_CR33","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1136\/bmjebm-2019-111174","volume":"24","author":"EE Nielsen","year":"2019","unstructured":"Nielsen EE, N\u00f8rskov AK, Lange T, Thabane L, Wetterslev J, Beyersmann J, et al. Assessing assumptions for statistical analyses in randomised clinical trials. BMJ evidence-based Med. 2019;24:185\u20139.","journal-title":"BMJ evidence-based Med"},{"key":"8305_CR34","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1186\/1745-6215-16-S2-P209","volume":"16","author":"M Clarke","year":"2015","unstructured":"Clarke M, Savage G, Maguire L, McAneney H. The SWAT (study within a trial) programme; embedding trials to improve the methodological design and conduct of future research. Trials. 2015;16:2015.","journal-title":"Trials"},{"key":"8305_CR35","first-page":"1","volume":"19","author":"S Treweek","year":"2018","unstructured":"Treweek S, Bevan S, Bower P, Campbell M, Christie J, Clarke M, et al. Trial Forge Guidance 1: what is a Study Within A Trial (SWAT)? Trials Trials. 2018;19:1\u20135.","journal-title":"Trials Trials"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-024-08305-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-024-08305-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-024-08305-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T09:07:29Z","timestamp":1721034449000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-024-08305-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,15]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["8305"],"URL":"https:\/\/doi.org\/10.1186\/s13063-024-08305-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3136591\/v1","asserted-by":"object"}]},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,15]]},"assertion":[{"value":"3 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The trial has been approved by the regional ethics committee for the Capital Region and the Region of Southern in Denmark under H-18054954 and in Norway by the regional ethics committee South-East for the University hospitals of Oslo and North Norway under REK-194073. All participants (or proxy) consent to participation in the trial.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"479"}}